Oral cavity carcinoma in situ
diseaseOn this page
Also known as carcinoma in situ of mouthcarcinoma in situ of oral cavitycarcinoma in situ of the mouthcarcinoma in situ of the oral cavitymouth carcinoma in situoral cavity in situ carcinomastage 0 carcinoma of mouthstage 0 carcinoma of oral cavitystage 0 carcinoma of the mouthstage 0 carcinoma of the oral cavitystage 0 mouth carcinomastage 0 oral cavity cancerstage 0 oral cavity cancer aJCC v6stage 0 oral cavity cancer aJCC v6 and v7stage 0 oral cavity cancer aJCC v7stage 0 oral cavity carcinoma
Summary
Oral cavity carcinoma in situ (MONDO:0000371) is a cancer. A subtype of in situ carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | oral cavity carcinoma in situ |
| Mondo ID | MONDO:0000371 |
| DOID | DOID:0050610 |
| ICD-11 | 1389868484 |
| NCIT | C4587 |
| SNOMED CT | 92660005 |
| UMLS | C0347073 |
| MedGen | 138076 |
| GARD | 0027525 |
| Anatomy (UBERON) | UBERON:0000167 |
| Is cancer (heuristic) | yes |
Also known as: carcinoma in situ of mouth · carcinoma in situ of oral cavity · carcinoma in situ of the mouth · carcinoma in situ of the oral cavity · mouth carcinoma in situ · oral cavity in situ carcinoma · stage 0 carcinoma of mouth · stage 0 carcinoma of oral cavity · stage 0 carcinoma of the mouth · stage 0 carcinoma of the oral cavity · stage 0 mouth carcinoma · stage 0 oral cavity cancer · stage 0 oral cavity cancer aJCC v6 · stage 0 oral cavity cancer aJCC v6 and v7 · stage 0 oral cavity cancer aJCC v7 · stage 0 oral cavity carcinoma
Disease family
This is a subtype of in situ carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › in situ carcinoma › oral cavity carcinoma in situ
Related subtypes (20): pharynx carcinoma in situ, gall bladder carcinoma in situ, adenocarcinoma in situ, nasal cavity carcinoma in situ, skin carcinoma in situ, breast carcinoma in situ, eye carcinoma in situ, lung carcinoma in situ, squamous carcinoma in situ, larynx carcinoma in situ, intestine carcinoma in situ, bladder carcinoma in situ, esophagus carcinoma in situ, uterus carcinoma in situ, liver carcinoma in situ, stomach carcinoma in situ, kidney carcinoma in situ, grade III prostatic intraepithelial neoplasia, carcinoma in situ of ureter, carcinoma in situ of urethra
Subtypes (1): lip carcinoma in situ
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.